Allergan, Inc. (AGN) Tops Q2 EPS by 1c; Guides FY12 EPS, Revs

August 1, 2012 9:01 AM EDT
Allergan, Inc. (NYSE: AGN) reported Q2 EPS of $1.07, $0.01 better than the analyst estimate of $1.06. Revenue for the quarter came in at $1.47 billion versus the consensus estimate of $1.5 billion.

Allergan, Inc. sees FY2012 EPS of $4.15-$4.19, versus the consensus of $4.17. Allergan, Inc. sees FY2012 revenue of $5.65-$5.80 million, versus the consensus of $5.85 million.

For earnings history and earnings-related data on Allergan, Inc. (AGN) click here.

Serious News for Serious Traders! Try Premium Free!

You May Also Be Interested In

Related Categories

Earnings, Guidance

Related Entities


Add Your Comment